MAVS and viral infectious disease: TRIM18 was shown to recruit protein phosphatase 1A (PPM1A) to dephosphorylate TBK1, which inactivates TBK1 and blocks its interactions with upstream adaptors MAVS and STING, thereby dampening type I IFN mediated antiviral signaling during viral infections.